CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Abbvie Inc.  (ABBV)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 
Price: $74.6300 $0.62 0.838%
Day's High: $ 75.04 Week Perf: 2.65 %
Day's Low: $ 73.85 30 Day Perf: 4.61 %
Volume (M): 4,961 52 Wk High: $ 75.04
Volume (M$): $ 370,269 52 Wk Avg: $ 64.47
Open: 73.98 52 Wk Low: 55.06
  ABBV Charts & Quotes
You need to upgrade your Flash Player

 Market Capitalization (Millions $) 119,632
 Shares Outstanding (Millions) 1,603
 Employees 26,000
 Revenues (TTM) (Millions $) 26,218
 Net Income (TTM) (Millions $) 6,310
 Cash Flow (TTM) (Millions $) -2,816
 Capital Exp. (TTM) (Millions $) 453
Abbvie Inc.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.


 

Abbvie's Segments
 
HUMIRA
 Segment    64.66 % of total Revenue
Kaletra
 Segment    2.98 % of total Revenue
AndroGel
 Segment    3.14 % of total Revenue
Lupron
 Segment    3.56 % of total Revenue
Synthroid
 Segment    3.33 % of total Revenue
Other
 Segment    5.5 % of total Revenue
Synagis
 Segment    1.65 % of total Revenue
Sevoflurane
 Segment    2.16 % of total Revenue
Creon
 Segment    2.85 % of total Revenue
VIEKIRA
 Segment    8.32 % of total Revenue
Dyslipidemia products
 Segment    0.76 % of total Revenue
 
  Company Estimates  
  Revenue Outlook
Abbvie does not provide revenue guidance.

Earnings Outlook
Abbvie Inc. issued annual earnings guidance on Jul. 24, 2015

 
Geographic Revenue Dispersion
United States 56.37 %
Japan 3.02 %
Germany 5.38 %
Canada 2.86 %
The Netherlands 5.04 %
Italy 2.25 %
All Other Countries 17.01 %
Brazil 2.26 %
Spain 2.78 %
France 3.04 %

Hexcel Corp

Double Digit EPS Growth, Sales Lower

Despite soft demand in the first quarter, company has managed to raise it's earnings per share, income increased by 18.64 % to $0.70 per share while Sales fell by -3.8 % to $478.80 millions, year on year.

Colgate Palmolive Co

Deterioration in Earnings, Sales Down Slightly

Colgate Palmolive Co announced disappointing results, eps deteriorated by -11.94 % to $0.59 from $0.67 and Sales declined by -0.49 % to $3.83 billions in the second quarter, year on year.


ABBV's Valuation Current
Price to Earnings PE Ratio (TTM) 19.31
Price to Earnings PE Ratio (Expected) 22.21
Price to Sales (TTM) 4.56
Price to Sales (Expected) -
Price to Book 23.94
PEG (TTM) 1
ABBV's Financial Strength Current
Quick Ratio 0.71
Working Capital Ratio 1.76
Leverage Ratio (MRQ) 12.14
Total Debt to Equity 7.39
Interest Coverage (TTM) 10.38
Debt Coverage (TTM) 0.28
Per Share Current
Earnings (TTM) 3.86 $
Revenues (TTM) 16.36 $
Cash Flow (TTM) -1.76 $
Cash 3.9 $
Book Value 3.12 $
Dividend (TTM) 2.42 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
ABBV's Efficiency Current
Revenue per Employee (TTM) 1,008,385
Net Income per Employee (TTM) 242,692
Receivable Turnover Ratio (TTM) 5.38
Inventory Turnover Ratio (TTM) 3.89
Asset Turnover Ratio (TTM) 0.39
ABBV's Profitability Ratio Current
Gross Margin 75.28 %
Operating Margin 37 %
Net Margin 26.17 %
Net Cash Flow Margin -
Effective Tax Rate (TTM) 22.99 %
Management Effectiveness Current
Return On Assets (TTM) 9.38 %
Return On Investment (TTM) 11.04 %
Return On Equity (TTM) 116.08 %
Dividend Yield 3.43 %
Payout Ratio (TTM) 62.61 %
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness


   
Customers Net Income fell by ABBV's customers Net margin fell to %
-4.31 % 3.68 %
   
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers
You need to upgrade your Flash Player


You need to upgrade your Flash Player

   
You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
     
BIIB        0.75% 
AMGN        1.74% 
GILD        4.52% 
ABT        3.95% 
JNJ        2.04% 
CELG        2.36% 
• View Complete Report
   



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com